Elicio Therapeutics, Inc.（ELTX）内部人交易：高管与董事近期交易
过去 18 个月，共有 4 位内部人为 Elicio Therapeutics, Inc.（ELTX）报告了 5 笔 Form 4 交易（最近一笔 2026-02-03）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-03 | Haqq Christopher | Executive Vice President, Head of R&D and Chief Medical Officer | 买入 | 25,400 | $0 |
| 2026-02-03 | DeMuth Peter | Chief Scientific Officer | 买入 | 20,800 | $0 |
| 2026-02-03 | Shah Preetam | Chief Strategy and Financial Officer | 买入 | 24,000 | $0 |
| 2026-02-03 | Connelly Robert | CEO, President and Director | 买入 | 73,600 | $0 |
| 2025-12-10 | DeMuth Peter | Chief Scientific Officer | 买入 | 362 | $1,596 |
来源：SEC Form 4 申报文件 · 截至 2026-02-03